CMPK1

Across TCGA pan-cancer cohorts, CMPK1 mass-spec protein is linked to patient survival in 7 of 34 cancer types, making it a survival-associated CMPK1 data layer compared with 26 for mass-spec protein and 3 for mutation status.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher CMPK1 mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated CMPK1 expression acts as an unfavorable survival marker, although some lineages such as COAD and PDAC show a favorable association.

COAD, PDAC, and UCEC are the cancer types where CMPK1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	DFS	Median	All	1.000	0.887	.022	48	view →
PDAC	OS	Quartile	II,III,IV	0.638	0.320	.008	43	view →
UCEC	DFS	Tertile	All	1.000	0.787	.002	28	view →
GBM	OS	Median	All	0.279	0.468	.005	25	view →
LUAD	DFS	Quartile	II,III,IV	0.675	0.214	.018	6	view →
CCRCC	DFS	Quartile	II,III,IV	0.933	0.728	.029	5	view →
LSCC	OS	Median	All	0.699	0.883	.016	2	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

CMPK1–COAD (DFS)

Open the COAD breakdown →